References
- Hurwitz HI, McGuire WP Primary chemotherapy in epithelial ovarian cancer. Obstet Gynecol Clin North Am 1994; 21(1): 141–54.
- Gershenson DM, Copeland LJ, Wharton JT, Atkinson EN, Sneige N, Edwards CI. Prognosis of surgical determined complete responders in advanced ovarian cancer. Cancer 1985; 55: 1129–35.
- Podratz KC, Malkasian GD, Jr, Wieland HS, Cha SS, Lee RA, Stanhope CR. Recurrent disease after negative second-look laparotomy in stage III and IV ovarian carcinoma. Gynecol Oncol 1988; 29: 274–82.
- Rubin SC, Hoskins WJ, Saigo PE, Chapman D, Hakes TB, Markman M et al. Prognostic factors for recurrence following negative second-look laparotomy in ovarian cancer patients treated with platinum-based chemotherapy. Gynecol Oncol 1991; 42: 137–41.
- Gershenson DM, Kavanagh JJ, Copeland LJ, Stringer CA, Morris M, Wharton JT. Re-treatment of patients with recurrent epithelial ovarian cancer with cisplatin based chemotherapy. Obstet Gynecol 1989; 73: 709–802.
- Gore ME, Fryatt I, Wiltshaw E, Dawson T. Treatment of relapsed carcinoma of the ovary with cisplatin or carboplatin following initial treatment with these compounds. Gynecol Oncol 1990; 36: 207–12.
- Morris M, Gershenson DM, Wharton JT, Copeland LJ, Edwards CL, Stringer CA. Secondary cytoreductive surgery for recurrent epithelial ovarian cancer. Gynecol Oncol 1989; 34: 334–8.
- Janicke F, Holscher M, Kuhn W, von Hugo R, Pache L, Sievert JR et al. Radical surgical procedure improves survival time in patients with recurrrent ovarian cancer. Cancer 1992; 70: 2129–36.
- Vaccarello L, Rubin SC, Vlamis V Wong G, Jones WB, Lewis JL et al. Cytoreductive surgery in ovarian carcinoma patients with a documented previously complete surgical response. Gynecol Oncol 1995; 57: 61–5.
- Copeland LJ, Vaccarello L, Lawandowski GS. Second-look laparotomy in epithelial ovarian cancer. Obstet Gynecol Clin North Am 1994; 21(1): 155–66.
- Kaplan EL, Meier P. Non parametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457–81.
- Mantel N, Haenszel W Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959; 22: 719–48.
- Berek JS, Hacker NF, Lagasse LD, Nieberg RK, Elashoff RM. Survival of patients following secondary cytoreductive surgery in ovarian cancer. Obstet Gynecol 1983; 61(2): 189–93.
- Segna RA, Dottino PR, Mandeli JP et al. Secondary cytoreduction for ovarian cancer following cisplatin therapy. J Clin Oncol 1993; 11: 434.
- Morris M, Gershenson DM, Wharton JT. Secondary cytoreductive surgery in epithelial ovarian cancer: nonresponders to first-line therapy. Gynecol Oncol 1989; 33: 15.
- Vogl SE, Seltzer V, Calanog A, Moukhtar M, Camacho F, Kaplan BH et al. Second effort surgical resection for bulky ovarian cancer. Cancer 1984; 54: 2220–5.
- Hoskins WJ, Rubin SC, Dulaney E, Chapman D, Almadrones L, Saigo PE et al. Influence of secondary cytoreduction at the time of second look laparotomy on the survival of patients with epithelial ovarian carcinoma. Gynecol Oncol 1989; 34: 365–71.